Generics

The Prevacid brand and generic had a market value of approximately $87 million, for the 12 months ended December 2020, according to IQVIA.

The Association for Accessible Medicine and its Biosimilars Council shared their policy priorities with the Biden administration and 117th Congress, while also kicking off a new advocacy campaign, dubbed “Secure Our Meds.”

Aurobindo’s droxidopa capsules are available in dosage strengths of 100 mg, 200 mg and 300 mg.

Droxidopa capsules are available from Camber in a dosage strength of 300 mg in a 90-count bottle.

The Prolixin brand and generic had a market value of $134 million for the 12 months ended December 2020, according to IQVIA.

Posaconazole had a market value of roughly $186 million, according to IQVIA December 2020 data.

ANI's new executive team includes Christopher Mutz as chief commercial officer and head of rare diseases, Ori Gutwerg as senior vice president of generics, and Davinder Singh as general manager of Canadian operations.

The Xeloda brand and generic had a market value of $90 million for the year ended October 2020, according to IQVIA.